Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 82 791 | déclaré | 20 mars 2026 | tx 42+473 228−104 222 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 20 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2 989 | 66.75 USD | |
| 18 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 3 610 | 68.71 USD | |
| 19 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 589 | 67.00 USD | |
| 17 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 3 125 | 69.42 USD | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 26 287 | — | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 020 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 148 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 022 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 097 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 17 161 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 27 310 | 0.00 USD | deriv |
| 04 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 8 366 | 76.67 USD | |
| 16 déc. 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 475 | 0.00 USD | |
| 16 déc. 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 950 | 0.00 USD | |
| 18 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2 605 | 46.29 USD | |
| 19 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2 543 | 47.40 USD | |
| 20 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2 435 | 50.11 USD | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 21 264 | — | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 148 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 019 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 097 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30 628 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20 089 | 0.00 USD | deriv |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 13 245 | — | |
| 18 mars 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4 879 | 30.60 USD |